Caris Downgrades Endo Pharmaceuticals (ENDP) to Average, Raises Price Target
Tweet Send to a FriendGet Alerts ENDP Hot Sheet
Price: $34.28 --0%
Rating Summary:
7 Buy, 11 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
7 Buy, 11 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Trade ENDP Now!
Caris & Co. downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) to an Average rating from its previous rating of Above Average. They are also raising their price target to $38 from from $28.
For more ratings news on Endo Pharmaceuticals Holdings Inc click here and for the rating history of Endo Pharmaceuticals Holdings Inc click here.
Shares of Endo Pharmaceuticals Holdings Inc closed at $36.46 yesterday, with a 52 week range of $19.11-$38.20.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Endo Pharmaceuticals Holdings Inc click here and for the rating history of Endo Pharmaceuticals Holdings Inc click here.
Shares of Endo Pharmaceuticals Holdings Inc closed at $36.46 yesterday, with a 52 week range of $19.11-$38.20.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: JPMorgan Cuts SodaStream (SODA) to Neutral, 'Stock No Longer Cheap'
- BGC Partners Downgrades DuPont (DD) to Sell
- Credit Suisse Downgrades ReneSola Ltd. (SOL) to Underperform
Create E-mail Alert Related Categories
Downgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
